In one paragraphArticle in NAR cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Nikolay V GoncharovSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0002-9106-4901 Ivan N BaklanovSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0002-4632-4508 Valeriia S GulaiaSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.
Anastasiia P ShuliakSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0003-3441-3906 Daria V LanskikhSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0003-4262-8325 Valeriia M ZhmeniaSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.
Mikhail E ShmelevSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0001-7106-1001 Nikita A ShvedSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.
Mikhail LiskovykhDevelopmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD 20892, United States.ORCID 0000-0002-6760-8331 Vladimir LarionovDevelopmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD 20892, United States.
Natalay KouprinaDevelopmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD 20892, United States.ORCID 0000-0001-8690-5625 Vadim V KumeikoSchool of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok 690922, Russia.ORCID 0000-0002-1639-664X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Recently revised brain tumor classification suggested a glioma treatment strategy that takes into consideration molecular variants in
Indexed as
Brain NeoplasmsChromosomal InstabilityGliomaIsocitrate DehydrogenaseTumor Suppressor Protein p53Cell Line, TumorHumansMutation, MissensePaclitaxelTemozolomideIDH1 protein, humanIsocitrate DehydrogenasePaclitaxelTemozolomideTP53 protein, humanTumor Suppressor Protein p53
Identifiers
PMID39949830
PMCPMC11822378
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390